NEW YORK, Feb. 5 – Compgen today reported revenue decreases for the fourth quarter and for the year today.

The Tel Aviv, Israel-based company saw revenues fall to $11.1 million in 2002 from $11.4 million for 2001, and $2.7 million in the fourth quarter compared to $3.1 million for the year-ago quarter.

The company said it began 2003 with $67.3 million in cash and cash-related accounts with an anticipated burn rate for 2003 of $15.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.